JMB-HEADER NAUKA RAS RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 52(2018) N 4 p. 548-555; DOI 10.1134/S0026893318040039 Full Text

V.I. Butvilovskaya1*, O.V. Smoldovskaya1, G.U. Feyzkhanova1 , M.A. Filippova1, L.V. Pavlushkina2, S.A. Voloshin1, A.Yu. Rubina1

Modification of Anti-Glycan IgG and IgM Profiles in Allergic Inflammation

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia
2Filatov Moscow Pediatric Clinic no. 13, Healthcare Department of Moscow, Moscow, 123001 Russia

*v.butvilovskaya@gmail.com
Received - 2017-11-15; Accepted - 2017-11-29

Glycans and anti-glycan antibodies (AGAs) are essential for infiltration of inflammatory cells in various allergies. The glycocalyx structure of the cells is modified during disease progression, and this modification is possible to evaluate by assessment of AGAs. A printed glycan array with 55 immobilized glycans and immobilized antibodies to IgG, IgA, and IgM was used to study the changes in AGA profiles in bronchial asthma (BA). Levels of antibodies to certain glycans in BA patients statistically differed from levels in healthy donors (p < 0.0007 by the Mann-Whitney test); the glycan set included 6Su-6`-SiaLec, Sia LeX, Sia6Htype2; Tαα, Manβ1-4GlcNAc, and Manα1-4Manβ. The obtained results help to better understand the mechanisms of the cell-mediated immune response in bronchial asthma and other types of allergic reactions.

allergy, bronchial asthma, anti-glycan antibodies, glycan array, immune response, siglecs, galectins



JMB-FOOTER RAS-JOURNALS